400 MS patients join study to see which treatment slows brain shrinkage best
NCT ID NCT05962177
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This study follows 400 people with relapsing-remitting multiple sclerosis (MS) for 3 years. Researchers will use MRI scans to measure brain shrinkage and compare those on high-efficacy treatments versus medium-efficacy treatments. The goal is to understand which treatment better slows disease progression and identify new ways to track MS over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neurology Department, Hopital Gui de Chauliac
RECRUITINGMontpellier, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.